Received: 17 May 2020
Accepted: 23 June 2020
First Online: 8 July 2020
Ethics approval and consent to participate
: This trial was carried out according to the good clinical practice and the Declaration of Helsinki. All patients signed an informed written consent detailing the investigational nature of the trial. The study was approved by the hospital’s institutional review board (IRB), RAC# 2081-068. Patients’ confidentiality was maintained throughout the study. The trial was registered at ExternalRef removed (NCT 01311050).
: This study is accepted as a poster presentation at the ESMO 22nd World Congress on Gastrointestinal Cancer. The manuscript has not been published or presented elsewhere in part or in entirety and is not under consideration by another journal.
: We have no conflicts of interest to declare.